Powercol (Q3989118): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: Fix Beneficiary from Netherlands) |
||
| Property / beneficiary name (string) | |||
HCM Medical B.V. | |||
| Property / beneficiary name (string): HCM Medical B.V. / rank | |||
Normal rank | |||
| Property / beneficiary | |||
| Property / beneficiary: Q3985885 / rank | |||
Normal rank | |||
Revision as of 09:25, 16 December 2021
Project Q3989118 in Netherlands
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Powercol |
Project Q3989118 in Netherlands |
Statements
96,556.78 Euro
0 references
551,753.0 Euro
0 references
17.5 percent
0 references
1 March 2016
0 references
28 February 2018
0 references
HCM Medical B.V.
0 references
51°49'37.02"N, 5°46'45.01"E
0 references
6546BJ
0 references
7130 AA
0 references
7500 BB
0 references
Samenwerkingspartners ontwikkelen een nieuw product, genaamd Powercol, waarmee ernstige zware bloedingen binnen max. 3 minuten (voor de meest heftige bloedingen) gestelpt kunnen worden. Powercol wordt zo ontwikkeld dat deze direct als eindproduct ... (Dutch)
0 references
Cooperation partners are developing a new product called Powercol, which can cause severe bleeding within a maximum of 3 minutes (for the most severe bleeding). Powercol is developed in such a way that it is directly as a final product... (English)
15 December 2021
0 references
Les partenaires de coopération mettent au point un nouveau produit appelé Powercol, qui peut causer des saignements graves dans un délai maximum de 3 minutes (pour les saignements les plus graves). Powercol est développé de telle manière qu’il est directement comme un produit final... (French)
15 December 2021
0 references
Kooperationspartner entwickeln ein neues Produkt namens Powercol, das innerhalb von maximal 3 Minuten schwere Blutungen verursachen kann (für die schwersten Blutungen). Powercol wird so entwickelt, dass es direkt als Endprodukt... (German)
15 December 2021
0 references
Identifiers
OP-2014-2023-Oost-PROJ-00463
0 references